How to Get a Medical Cannabis Licence in Israel (2026 Guide)

Israel was one of the first countries in the world to build a state-run medical cannabis programme, and as of May 2026 it licenses about 143,900 patients — an all-time high, and one of the highest per-capita rates anywhere (Cannabis Magazine, 12 July 2026). That figure follows a dip rather than a straight climb: the count reached 140,483 in January 2024, fell roughly 7.5% to about 129,900 by March 2025 as the health funds tightened gatekeeping, and has since recovered (Times of Israel, Journal of Cannabis Research, 2025). But the route to a permit is specific, it depends on your condition, and a reform that would rebuild it is sitting on the shelf — frozen rather than abandoned. This guide explains how to get a medical cannabis licence in Israel as the system works today, in mid-2026, and what that reform would do to it if it ever revives.

This guide is informational and is not medical advice. Treatment decisions should be made with a licensed physician.

Who issues the licence

Medical cannabis in Israel is regulated by the Ministry of Health through its Medical Cannabis Unit — known in Hebrew as Yakar, and in English as the Israel Medical Cannabis Agency (IMCA). The unit licenses patients, sets the products and monthly quantities they may receive, and oversees the producers and pharmacies that supply them (Ministry of Health).

Recent reform split the prescribing pathway in two. As the "last resort" requirement was removed, authority for most indications was devolved to Israel's four public health funds (HMOs) — Clalit, Maccabi, Meuhedet and Leumit — while a smaller set of indications, notably chronic pain and PTSD, stayed under the direct authority of the Medical Cannabis Unit (Journal of Cannabis Research, 2025). So the first practical question is not "how do I apply" but "which route does my condition sit on?" — the paperwork differs.

The Ministry's own guidance now distinguishes between applying "through a specialist who is authorized to issue the permit immediately" and "through a specialist who must apply to the Medical Cannabis Unit on your behalf" (Ministry of Health). That single sentence is the whole system in miniature.

Step 1: See the right specialist

The process begins with a specialist physician who treats your condition — an oncologist for cancer, a neurologist for epilepsy or Parkinson's, a gastroenterologist for inflammatory bowel disease, a pain-clinic physician for chronic pain, a psychiatrist for PTSD. A general practitioner generally cannot initiate a cannabis recommendation; the specialist must be willing to recommend cannabis and to document why it is clinically appropriate (Leumit Health Services).

Since the 2024 reform, specialists may use clinical discretion within their area of expertise rather than prescribing cannabis only after every conventional treatment has failed (Journal of Cannabis Research, 2025). In practice, this remains the single hardest step: the entire process turns on finding a specialist who is both treating you and willing to write the recommendation. Everything downstream is administration.

Step 2: The recommendation is submitted

If the specialist agrees, they complete the application — typically an online form on the Ministry of Health system — and attach supporting documentation: a summary of your medical history and a record of the treatments already tried, often drawn from your family doctor's file (Nefesh B'Nefesh).

Where authority sits with your HMO, an authorised specialist may issue the prescription more or less directly. Where the indication remains with the Medical Cannabis Unit — chronic pain and PTSD, the two largest indications between them — the recommendation goes for central review first.

Step 3: Approval, and how long it takes

If approved, the licence specifies the monthly quantity you may purchase and the treatment period, after which it must be renewed. Timelines vary sharply by route. An HMO-issued prescription can be quick; where central review is required, applicants are commonly told to allow two to three months for a decision. It is worth confirming about ten days after submission that the unit has actually received the file (Nefesh B'Nefesh). The unit answers by email and fax during standard weekday hours (Ministry of Health).

Renewal is never automatic — it is a fresh clinical decision each time. But the much-quoted six-month rule is not yet a rule. Under the recommendations published on 3 May 2026, renewing a prescription beyond six months would require an actual meeting with the prescribing physician rather than a paper renewal (Times of Israel) — but the health minister froze those recommendations on 6 May 2026 and none of them is in force. Renewal intervals today remain what they have been: typically three, six or twelve months depending on the case, through whichever authority holds your indication. See renewing a medical cannabis licence in Israel for how that actually works.

Step 4: Choosing a product and pharmacy

Once licensed, you fill the prescription at a pharmacy authorised to dispense cannabis. Products are categorised by THC and CBD content and supplied as dried inflorescence (flower), oils, extracts and metered-dose inhalers, and a cannabis-licensed pharmacist advises on the specific product and titration within the parameters of your licence.

Flower currently dominates: about 88% of licences are for high-THC preparations, and smoking accounts for the overwhelming majority of consumption (Times of Israel). That is precisely what the May 2026 reform proposed to change (below).

What it costs

Medical cannabis is not in the national health basket, so patients largely pay out of pocket — HMO charges for the examination, permit and prescription, then the product cost at the pharmacy, which varies because pharmacies set their own prices. Certain patients, notably disabled IDF veterans treated through the Ministry of Defense, have treatment funded. For the full fee breakdown, see how much medical cannabis costs in Israel.

What could change next: the May 2026 reform, and the freeze

On 3 May 2026 a Health Ministry committee chaired by Dr. Gilad Bodenheimer, head of the ministry's mental health division, published recommendations that would reshape this process again (Times of Israel; Hemp Gazette). Three items matter most to an applicant:

• Everything moves to the HMOs. Within roughly a year, diagnosis, approval, monitoring and dispensing would all sit inside your health fund, integrated into your medical record — ending the two-track split described above.
• Smoking is phased out over three years, in favour of extracts, oils and precision inhalers, with exceptions floated only for patients over 75 and the terminally ill.
• Tighter gatekeeping: addiction-risk assessment before treatment starts, the six-month in-person renewal meeting, and notably stricter criteria for PTSD — see medical cannabis for PTSD in Israel.

These are recommendations, not law — and they are currently going nowhere. On 6 May 2026, three days after publication, Health Minister Haim Katz instructed the ministry's director-general to halt all work on implementing them, saying he was not sufficiently convinced there was justification for doing so "given the potential harm to patients" (StratCann). Nothing in that list applies to an application you make today.

A freeze is not a repeal, though, and the direction of travel is unambiguous: from a permit system that grew fast and loosely toward a conventional, insurer-run prescription system with more clinical friction. The full account is in is Israel banning smoked medical cannabis?.

The bottom line

Find a specialist in your condition who is willing to recommend cannabis; expect the HMO route to be faster than the Medical Cannabis Unit route; allow two to three months if your file goes to central review; and treat the May 2026 reform as frozen rather than settled — it changes nothing about the application you make today, but it has not been withdrawn either.

For which conditions qualify, see qualifying conditions for medical cannabis in Israel. Visitors should read cannabis in Israel for tourists — foreign licences are not recognised. The wider picture lives on our Patient Access hub, and the legal framework behind it in is cannabis legal in Israel?